Cannabis use prevalence before and early after partial legalisation in Germany
Kotz, D.; Manthey, J.; Klosterhalfen, S.; Steinhoff, P.; Viechtbauer, W.
Show abstract
Background and AimsOn April 1st, 2024, Germany implemented the Act on the Handling of Cannabis for Non-Medical Use (KCanG), allowing adults to cultivate and possess recreational cannabis. We assessed whether this policy shift was associated with a change in the prevalence of cannabis use in the general population and in daily or almost daily cannabis use. DesignA series of 21 repeated cross-sectional surveys conducted between April/May 2022 and October/November 2025 (covering the period approximately two years before and one and a half years after the KCanG). SettingPopulation of Germany. ParticipantsA total of 32,991 people aged 14-64 years, including 2,092 (6.3%) people who used cannabis in the past 12 months. MeasurementsPast 12-month cannabis use (at least once). In past 12-month users: daily or almost daily use. To test a potential change in prevalence following the KCanG, we used piecewise binomial logistic regression models using the exact date of each wave as the predictor variable, allowing for a change in the slope at the first full wave after implementation of the KCanG in April 2024, with a random effect for wave. We conducted this analysis for the total sample as well as stratified by gender (male vs. female), age (14-24 vs. 25-64 years), and for daily or almost daily cannabis use in the subgroup of people who used cannabis in the past 12 months. Sensitivity analyses used alternate intervention dates (in-time placebo tests). FindingsThe prevalence of cannabis use and the share of (almost) daily users among 12-month users remained largely stable before and after the law reform. None of the slope coefficients before the introduction of the KCanG were statistically significant (all p [≥] .08), and none of the coefficients for the change in the slope were statistically significant (all p [≥] .31). Results of sensitivity analyses confirmed the stable trends for both outcomes. ConclusionsThe legislation of cannabis introduced in Germany in April 2024 was not associated with a change in trends of 12-month cannabis use prevalence early (1.5 years) after implementation, and also not with a change in the proportion of heavy users among past-12-month users. We recommend continued close monitoring of trends using multiple data sources and over a longer post-implementation period, as the effects of the legislation may not have fully unfolded yet.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Transitions from smoking to exclusive e-cigarette use, dual use, or stopping nicotine use in ALSPAC and their association with modifiable and sociodemographic factors 94%
- Cannabis use, depression and self-harm: phenotypic and genetic relationships 93%
- Moderators of changes in smoking, drinking, and quitting behaviour associated with the first Covid-19 lockdown in England 93%
Similar papers in this journal
- Sex and Gender Influences on Problematic Cannabis Use and Cannabis Use Disorder: A Scoping Review Protocol 95%
- A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two years 94%
- Commercial Cannabis Product Testing: Fidelity to Labels and Regulations 94%
Similar papers in this journal
- Changes in injecting versus smoking heroin, fentanyl, and methamphetamine among people who inject drugs in San Diego, California, 2020 to 2023 92%
- Fentanyl, Heroin, and Methamphetamine-Based Counterfeit Pills Sold at Tourist-Oriented Pharmacies in Mexico: An Ethnographic and Drug Checking Study 92%
- Cannabis Use and Sleep Quality in Daily Life: a Daily Diary Study of Adults Starting Cannabis for Health Concerns 92%
Similar papers in this journal
- Impact on alcohol selection and purchasing of increasing the proportion of non-alcoholic versus alcoholic drinks: randomised controlled trial 91%
- Rare but elevated incidence of hematological malignancy after clozapine use in schizophrenia: a population cohort study 90%
- Clinical benefits of modifying the evening light environment in an acute psychiatric unit: A single-centre, two-arm, parallel-group, pragmatic effectiveness randomised controlled trial 89%
Similar papers in this journal
- Prevalence and uptake of vaping among people who have quit smoking: a population study in England, 2013-2024 92%
- Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009. 90%
- Establishing the causal role of intimate partner violence and abuse on depressive symptoms in young adults: a population-based cohort study 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.